These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22126489)

  • 1. Proteomics analysis and evaluation of biomarkers for detection of cholangiocarcinoma.
    Sriwanitchrak P; Viyanant V; Chaijaroenkul W; Srivatanakul P; Gram HR; Eursiddhichai V; Na-Bangchang K
    Asian Pac J Cancer Prev; 2011; 12(6):1503-10. PubMed ID: 22126489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective proteomic-based study for identifying potential biomarkers for the diagnosis of cholangiocarcinoma.
    Shi Y; Deng X; Zhan Q; Shen B; Jin X; Zhu Z; Chen H; Li H; Peng C
    J Gastrointest Surg; 2013 Sep; 17(9):1584-91. PubMed ID: 23868055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic Features of Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis.
    Ishii Y; Sasaki T; Serikawa M; Kobayashi K; Kamigaki M; Minami T; Okazaki A; Yukutake M; Ishigaki T; Kosaka K; Mouri T; Yoshimi S; Chayama K
    Hepatogastroenterology; 2014 May; 61(131):567-73. PubMed ID: 26176037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches.
    Silsirivanit A; Sawanyawisuth K; Riggins GJ; Wongkham C
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):388-96. PubMed ID: 24616382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice.
    Sombattheera S; Proungvitaya T; Limpaiboon T; Wongkham S; Wongkham C; Luvira V; Proungvitaya S
    Asian Pac J Cancer Prev; 2015; 16(4):1367-70. PubMed ID: 25743800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
    Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
    Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
    Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM
    Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State of serum markers for detection of cholangiocarcinoma.
    Wongkham S; Silsirivanit A
    Asian Pac J Cancer Prev; 2012; 13 Suppl():17-27. PubMed ID: 23480761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma.
    Tang Z; Yang Y; Wang X; Meng W; Li X
    BMJ Open; 2019 Jan; 9(1):e021693. PubMed ID: 30700476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach.
    Pattanapairoj S; Silsirivanit A; Muisuk K; Seubwai W; Cha'on U; Vaeteewoottacharn K; Sawanyawisuth K; Chetchotsak D; Wongkham S
    Clin Biochem; 2015 Jul; 48(10-11):668-73. PubMed ID: 25863112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma.
    Tolek A; Wongkham C; Proungvitaya S; Silsirivanit A; Roytrakul S; Khuntikeo N; Wongkham S
    Exp Biol Med (Maywood); 2012 Oct; 237(10):1142-9. PubMed ID: 23104505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.
    Lapitz A; Azkargorta M; Milkiewicz P; Olaizola P; Zhuravleva E; Grimsrud MM; Schramm C; Arbelaiz A; O'Rourke CJ; La Casta A; Milkiewicz M; Pastor T; Vesterhus M; Jimenez-Agüero R; Dill MT; Lamarca A; Valle JW; Macias RIR; Izquierdo-Sanchez L; Pérez Castaño Y; Caballero-Camino FJ; Riaño I; Krawczyk M; Ibarra C; Bustamante J; Nova-Camacho LM; Falcon-Perez JM; Elortza F; Perugorria MJ; Andersen JB; Bujanda L; Karlsen TH; Folseraas T; Rodrigues PM; Banales JM
    J Hepatol; 2023 Jul; 79(1):93-108. PubMed ID: 36868481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma.
    Silsirivanit A; Matsuda A; Kuno A; Tsuruno C; Uenoyama Y; Seubwai W; Angata K; Teeravirote K; Wongkham C; Araki N; Takahama Y; Wongkham S; Narimatsu H
    Clin Chim Acta; 2020 Nov; 510():142-149. PubMed ID: 32659223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
    Liang B; Zhong L; He Q; Wang S; Pan Z; Wang T; Zhao Y
    Med Sci Monit; 2015 Nov; 21():3555-63. PubMed ID: 26576628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between circulating MicroRNA-150 level and cholangiocarcinoma.
    Salem PES; Ghazala RA; El Gendi AM; Emara DM; Ahmed NM
    J Clin Lab Anal; 2020 Nov; 34(11):e23397. PubMed ID: 33161598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma.
    Lertpanprom M; Silsirivanit A; Tippayawat P; Proungvitaya T; Roytrakul S; Proungvitaya S
    Front Public Health; 2022; 10():835914. PubMed ID: 35991009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and surveillance for occupational cholangiocarcinoma in workers exposed to organic solvents.
    Kubo S; Takemura S; Tanaka S; Nishioka T; Kinoshita M; Hamano G; Ito T; Yamamoto T; Abue M; Aoki M; Nakagawa K; Hijioka S; Miyamoto A; Osaki Y; Endo G; Kumagai S
    Surg Today; 2016 Jun; 46(6):705-12. PubMed ID: 26228355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma.
    Gao L; Lin Y; Yue P; Li S; Zhang Y; Mi N; Bai M; Fu W; Xia Z; Jiang N; Cao J; Yang M; Ma Y; Zhang F; Zhang C; Leung JW; He S; Yuan J; Meng W; Li X
    BMC Med; 2023 Aug; 21(1):294. PubMed ID: 37553571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis.
    Duangkumpha K; Stoll T; Phetcharaburanin J; Yongvanit P; Thanan R; Techasen A; Namwat N; Khuntikeo N; Chamadol N; Roytrakul S; Mulvenna J; Mohamed A; Shah AK; Hill MM; Loilome W
    PLoS One; 2019; 14(8):e0221024. PubMed ID: 31425520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Bile Titer and High Bile to Serum Ratio of CYFRA 21 - 1 Reliably Discriminate Malignant Biliary Obstruction Caused by Cholangiocarcinoma.
    Chen J; Liang J; Xu B; Liang J; Ma M; Wang Z; Zeng G; Xu Q; Liang L; Lai J; Huang L
    J Gastrointest Cancer; 2024 Jun; 55(2):800-808. PubMed ID: 38280173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.